Simian immunodeficiency virus: Possible effects of deworming and tuberculin extrapolated to HIV/AIDS [1]

Vaccine

Volumn 21, Issue 19-20, 2003, Pages 2258-2259

  Fincham, John E ^a   Markus, Miles B ^b   Adams, Vera J ^a  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b Biomedica1 Analysis International ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; INTRADERMIC; TUBERCULIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELLULAR IMMUNITY; CERCOPITHECIDAE; DISEASE TRANSMISSION; DRUG EFFICACY; EPIDEMIC; HELMINTHIASIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INCIDENCE; INFECTION RISK; LETTER; MEDICAL RESEARCH; MYCOBACTERIUM; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RETROVIRUS; SERODIAGNOSIS; SIMIAN IMMUNODEFICIENCY VIRUS; TH2 CELL; TUBERCULOSIS; WORM INFECTION;

EID: 0037650210     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00061-6     Document Type: Letter

References (13)

1. Chujoh Y., Matsuo K., Yoshizaki H.et al. Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B′ strains by recombinant Mycobacterium bovis BCG-based candidate vaccine. Vaccine. 20:2001;797-804.
2. McMichael A., Mwau M., Hanke T. HIV T cell vaccines, the importance of clades. Vaccine. 20:2002;1918-1921.
3. Shen Y., Zhou D., Chalifoux L.et al. Induction of an AIDS virus-related tuberculosis-like disease in macaques: a model of simian immunodeficiency virus-mycobacterium coinfection. Infect. Immun. 70:2002;869-877.
4. Bentwich Z., Kalinkovich A., Weisman Z., Borkow G., Beyers N., Byers A.D. Can eradication of helminthic infections change the face of AIDS and tuberculosis? Immunol. Today. 20:1999;485-487.
5. Markus M.B., Fincham J.E. Helminthic infection and HIV vaccine trials. Science. 291:2001;46-47.
6. Fincham JE, Markus MB, Adams VJ. Could control of helminthic infection influence the HIV/AIDS pandemic? Acta Tropica, in press.
7. Markus M.B., Fincham J.E. Mbeki and AIDS in Africa. Science. 288:2000;2131.
8. Gardner M.B. The history of simian AIDS. J. Med. Primatol. 25:1996;148-157.
9. Diop O.M., Gueye A., Dias-Tavares M.et al. High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys. J. Virol. 74:2000;7538-7547.
10. Fincham J.E., Van der Riet F., Steytler J.G.et al. Increased peripheral lymphocytes, lymphoid hepatitis and anaemia in African vervet monkeys seropositive to retroviruses. J. Comp. Pathol. 101:1989;53-68.
11. + T lymphocytes in semen of chronically infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J. Virol. 73:1999;4508-4512.
12. Ruprecht R.M., Babo T.W., Liska V.et al. Oral transmission of primate lentiviruses. J. Infect. Dis. 179(Suppl 3):1999;S408-S412.
13. Sepulveda R.L., Ferrer X., Latrach C., Sorensen R.U. The influence of Calmette-Guérin bacillus immunization on the booster effect of tuberculin testing in healthy young adults. Am. Rev. Respir. Dis. 142:1990;24-28.